🇺🇸 FDA
Patent

US 6949568

Aryl aniline β2 adrenergic receptor agonists

expired A61PA61P43/00

Quick answer

US patent 6949568 (Aryl aniline β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P43/00